Susquehanna International Group’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Susquehanna International Group’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-57	Closed	-$13K	–	14326
2022 Q2	$13K	Sell	57 -117	-67%	-$29.9K	﹤0.01%	12465
2022 Q1	$48K	Sell	174 -65	-27%	-$18K	﹤0.01%	12332
2021 Q4	$52K	Sell	239 -397	-62%	-$143K	﹤0.01%	12523
2021 Q3	$289K	Sell	636 -215	-25%	-$107K	﹤0.01%	10688
2021 Q2	$501K	Sell	851 -218	-20%	-$115K	﹤0.01%	9591
2021 Q1	$669K	Buy	1,069 +1,017	+1,956%	+$654K	﹤0.01%	8781
2020 Q4	$23K	Sell	52 -31	-37%	-$13K	﹤0.01%	10872
2020 Q3	$31K	Buy	+83	New	+$90.5K	﹤0.01%	10323

Other funds holding VCNX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Susquehanna International Group's VCNX Position: Q2 2023 in Review

Susquehanna International Group sold out of Vaccinex, Inc. Common Stock (VCNX) in Q2 2023, closing a stake of 472 shares — an estimated $39.6K sold.

Susquehanna International Group first reported a position in VCNX in Q3 2020 and held it in 9 quarters. The position peaked at $327K in Q1 2021. 22 funds tracked by Wall St. Rank hold VCNX as of Q2 2023.

Susquehanna International Group reported no remaining Vaccinex, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 472 Vaccinex, Inc. Common Stock shares in Q2 2023, an estimated $39.6K.
Susquehanna International Group first reported a position in Vaccinex, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
Susquehanna International Group's Vaccinex, Inc. Common Stock position peaked at $327K in Q1 2021.
22 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.